Health Care & Life Sciences » Pharmaceuticals | Miraca Holdings Inc.

Miraca Holdings Inc. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
203,371
204,667
211,743
204,245
195,400
181,415
Cost of Goods Sold (COGS) incl. D&A
128,009
132,351
138,112
130,835
127,306
121,928
Gross Income
75,362
72,316
73,631
73,410
68,094
59,487
SG&A Expense
48,762
45,431
47,580
45,351
50,446
44,837
EBIT
26,600
26,885
26,051
28,059
17,648
14,650
Unusual Expense
844
3,596
20,106
6,214
10,640
397
Non Operating Income/Expense
910
1,897
325
15,622
12,728
323
Interest Expense
514
589
607
484
334
195
Pretax Income
26,130
24,331
3,598
4,438
7,083
11,375
Income Tax
10,808
8,329
8,679
4,105
7,341
4,989
Consolidated Net Income
15,322
16,002
5,081
333
257
6,386
Net Income
15,322
16,002
5,081
333
257
6,386
Net Income After Extraordinaries
15,322
16,002
5,081
333
257
6,386
Net Income Available to Common
15,322
16,002
5,081
333
257
6,386
EPS (Basic)
261.48
274.83
89.20
5.84
4.50
111.94
Basic Shares Outstanding
59
58
57
57
57
57
EPS (Diluted)
260.80
274.32
89.20
5.84
4.50
111.91
Diluted Shares Outstanding
59
58
57
57
57
57
EBITDA
41,317
42,255
41,044
41,181
27,286
24,354
Non-Operating Interest Income
32
21
30
45
62
464
Equity in Affiliates (Pretax)
53
286
1,444
1,346
1,091
3,471

About Miraca Holdings

View Profile
Address
Shinjuku Mitsui Building, 8/F
Tokyo Tokyo 163
Japan
Employees -
Website http://www.miraca-holdings.co.jp
Updated 07/08/2019
Miraca Holdings Inc. operates as a holding company which provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. It operates through the following segments: In Vitro Diagnostics, Clinical Laboratory Testing, and Healthcare Related. The In Vitro Diagnostic segment offers clinical laboratory testing services; collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back.